Tel Aviv, Israel

Giora Carni

USPTO Granted Patents = 7 


 

Average Co-Inventor Count = 5.6

ph-index = 3

Forward Citations = 83(Granted Patents)


Location History:

  • Tel Aviv, IL (2014 - 2017)
  • Jerusalem, IL (2017)

Company Filing History:


Years Active: 2014-2017

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Giora Carni: Innovator in Pharmaceutical Solutions

Introduction

Giora Carni is a notable inventor based in Tel Aviv, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurological disorders. With a total of 7 patents to his name, Carni's work focuses on innovative drug delivery systems that enhance patient care.

Latest Patents

One of Carni's latest inventions is the Accordion pill comprising levodopa for an improved treatment of Parkinson's Disease symptoms. This invention allows for the administration of levodopa in a twice-daily regimen, ensuring stable blood plasma levels over a 24-hour period. This method effectively treats the symptoms of Parkinson's disease, providing patients with a better quality of life. Another significant patent is the Zaleplon gastroretentive drug delivery system. This biodegradable, multi-layered dosage form is designed for controlled and immediate release of zaleplon, promoting efficient sleep induction with minimal next-day residual effects.

Career Highlights

Giora Carni is currently associated with Intec Pharma Ltd., where he continues to develop innovative pharmaceutical solutions. His work has garnered attention for its potential to improve treatment outcomes for patients suffering from various conditions.

Collaborations

Carni collaborates with talented individuals in his field, including Nadav Navon and David Kirmayer. Their combined expertise contributes to the advancement of pharmaceutical technologies.

Conclusion

Giora Carni's innovative contributions to the pharmaceutical industry demonstrate his commitment to improving patient care through advanced drug delivery systems. His patents reflect a deep understanding of the needs of patients and the complexities of treatment regimens.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…